Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.

Imagawa, Jun

Imagawa, Jun.

Affiliation

Imagawa J; a Department of Haematology and Oncology , Research Institute for Radiation Biology and Medicine, Hiroshima University , Hiroshima , Japan.

Leuk Lymphoma ; 59(12): 3013-3015, 2018 12.

Article in En | MEDLINE | ID: mdl-29616847

Subject(s)

Antineoplastic Agents/therapeutic use; Arsenic Trioxide/therapeutic use; Disseminated Intravascular Coagulation/chemically induced; Leukemia, Promyelocytic, Acute/drug therapy; Tretinoin/adverse effects; Adult; Aged; Disease Progression; Disseminated Intravascular Coagulation/pathology; Drug Substitution; Humans; Leukemia, Promyelocytic, Acute/pathology; Male; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Tretinoin / Leukemia, Promyelocytic, Acute / Disseminated Intravascular Coagulation / Arsenic Trioxide / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adult / Aged / Humans / Male Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google